| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 2e-09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.34 | 1e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.2 | 7e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |